Belumosudil: An effective oral steroid-sparing agent for chronic cutaneous graft-versus-host disease

J Eur Acad Dermatol Venereol. 2025 Oct;39(10):e905-e907. doi: 10.1111/jdv.20626. Epub 2025 Mar 3.

Authors

Amy J Petty¹, Colleen M Glennon^{1

2}, Emma Fixsen¹, Adela R Cardones³, Melodi Javid Whitley¹

Affiliations

¹ Department of Dermatology, Duke University School of Medicine, Durham, North Carolina, USA.
² School of Medicine, Creighton University, Phoenix, Arizona, USA.
³ Division of Dermatology, Department of Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA.

PMID: 40026211
DOI: 10.1111/jdv.20626

No abstract available

Publication types

Letter